新生内膜
细胞生长
蛋白激酶B
细胞生物学
生物
血管平滑肌
细胞周期
视网膜母细胞瘤蛋白
MAPK/ERK通路
信号转导
沃特曼宁
激酶
磷酸化
碘化丙啶
分子生物学
细胞
细胞凋亡
内科学
内分泌学
生物化学
程序性细胞死亡
医学
再狭窄
支架
平滑肌
作者
Daniel Sedding,Monique Tröbs,Fabian P. M. Reich,Gerhard Walker,Ludger Fink,Werner Haberbosch,Wigbert Stefan Rau,Harald Tillmanns,Klaus T. Preissner,Rainer Maria Bohle,Alexander Claus Langheinrich
出处
期刊:Circulation Research
[Lippincott Williams & Wilkins]
日期:2009-04-17
卷期号:104 (10): 1192-1200
被引量:25
标识
DOI:10.1161/circresaha.109.194357
摘要
3-Deazaadenosine (c3Ado) is a potent inhibitor of S-adenosylhomocysteine hydrolase, which regulates cellular methyltransferase activity. In the present study, we sought to determine the effect of c3Ado on vascular smooth muscle cell (VSMC) function and neointima formation in vivo. c3Ado dose-dependently prevented the proliferation and migration of human coronary VSMCs in vitro. This was accompanied by an increased expression of the cyclin-dependent kinase inhibitors p21(WAF1/Cip1), p27(Kip1), a decreased expression of G(1)/S phase cyclins, and a lack of retinoblastoma protein hyperphosphorylation. In accordance with these findings, fluorescence-activated cell-sorting analysis of propidium iodide-stained cells indicated a cell cycle arrest in the G(0)/G(1) phase. Importantly, c3Ado did not affect the number of viable (trypan blue exclusion) or apoptotic cells (TUNEL). Mechanistically, c3Ado prevented FCS-induced Ras carboxyl methylation and membrane translocation and activity by inhibiting isoprenylcysteine carboxyl methyltransferase and reduced FCS-induced extracellular signal-regulated kinase (ERK)1/2 and Akt phosphorylation in a dose-dependent manner. Conversely, rescuing signal transduction by overexpression of a constitutive active Ras mutant abrogated c3Ado's effect on proliferation. For in vivo studies, the femoral artery of C57BL/6 mice was dilated and mice were fed a diet containing 150 microg of c3Ado per day. c3Ado prevented dilation-induced Ras activation, as well as ERK1/2 and Akt phosphorylation in vivo. At day 21, VSMC proliferation (proliferating-cell nuclear antigen [PCNA]-positive cells), as well as the neointima/media ratio (0.7+/-0.2 versus 1.6+/-0.4; P<0.05) were significantly reduced, without any changes in the number of apoptotic cells. Our data indicate that c3Ado interferes with Ras methylation and function and thereby with mitogenic activation of ERK1/2 and Akt, preventing VSMC cell cycle entry and proliferation and neointima formation in vivo. Thus, therapeutic inhibition of S-adenosylhomocysteine hydrolase by c3Ado may represent a save and effective novel approach to prevent vascular proliferative disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI